The synthesis of well-defined polypeptides show complex macromolecular architecture requires the use of monomers that can be grouped by orthogonally grouped, containing primary amines that will be used as initiary for polymerization of the ring opening (ROP) anhydride n-carboxy. Synthesis and characterization of novel nε-9-fluorylmethoxycarbony-ls-carboxy anhydride (Na-FMOC-Lysine NCA), as well as linear poly novel (Nε-FMOC-L-Lys) n homopipeptide and poly (L-lysine) 78- Block- [Poly (L-Lysine) 10-graft-poly (L-Histidine) 15] Copolypeptide block-graft, served.

The copolypeptide graft synthesis was carried out through the NA-BOC-L-Lysine NCA ROP when using n-hexylamine as an initiator, followed by the polymerization of NCA Nε-FMOC-L-lysine. The latest blocks are selectively explored in basic conditions, and the resulting ε-amine is used as an initiation species for ROP NIM-Trity-L-Histidine NCA. Finally, the Board of Commissioners and Trt groups were sentenced by TFA. High vacuum techniques are applied to achieve the conditions needed for well-defined polypeptide synthesis. Molecular characterization shows that polypeptides show molecular homogeneity and high composition.

Finally, dynamic light scattering, ζ-potential, and a circular crocated measurement is used to investigate the ability of polypeptides to gather itself in different conditions. This monomer paves the way for polypeptide synthesis with complex macromolecular architecture that can define aggregation behavior, and, therefore, can cause the synthesis of responsive nanocarrier “smart” stimulation for controlled drug delivery applications.

Antimicrobial multifunctional polypeptide-selenium nanoparticles combating drug resistance bacteria

Antibiotic-resistant bacteria are severe threats to human health. The global global surveillance system of the Health Health Health has revealed antibiotic resistance between half a million patients in 22 countries, with Staphylococcus aureus, Escherichia coli, and Klebsiella pneumoniae became the most resistant species. Antimicrobial nanoparticles emerged as an alternative that promised antibiotics in the fight against antimicrobial resistance. In this work, selenium nanoparticles are coated with antimicrobial polypeptides, ε-poly-licin, (SE np-ε-pl) synthesized and antibacterial activity and cytotoxicity investigated. SE NP-ε-PL which shows significantly larger antibacterial activity of all eight species of bacteria tested, including gram-positive, gram-negative strains, and drug resistance, than their individual components, SE NP and ε-pl.

Nanoparticles do not show toxicity to human dermal fibroblasts at the minimum inhibitory concentration, showing therapeutic windows. Furthermore, unlike conventional kanamycin antibiotics, SE NP-ε-PL does not easily induce resistance to E. coli or S. aureus. In particular, S. aureus began developing resistance to Kanamycin from the generation of ~ 44, while needed ~ 132 generations for resistance to develop into SE np-ε-pl. Surprisingly, E. coli cannot develop resistance to nanoparticles above ~ 300 generations. These results indicate that the multifunctional approach to combining SE NP with ε-PL to form SE NP-ε-PL is a new strategy that is very efficacious with the antibacterial activity of the width spectrum, low cytotoxicity, and significant delay in the development of resistance.

Open polypeptides open surface are successfully used as targets to develop a one-step prototype immunochromatography strip for specific and sensitive direct detection of staphylococcus aureus which causes neonatal sepsis

Neonatal sepsis is a life-threatening condition and Staphylococcus aureus is one of the main causes. However, until now, there are no fast and sensitive diagnostic tools have been developed for direct detection. Bioinformatics analysis identifies 112 amino acid polypeptides exposed to the surface of the cell protein nwmn_1649 cell walls, surface protein involved in cell aggregation and biofilm formation, as specific species and moiety which is highly preserved.

Polypeptides are cloned, purified, and used to immunize mice to increase certain immunoglobulin. Purified antibodies are conjugated to gold nano particles and are used to assemble immunochromatographic strips (ICS). The prototype IC developed is detected as low as 5 μg of pure polypeptides and 102 CFU / ML S. aureus in 15 minutes. The strip shows superior ability to directly detect S. aureus in the blood specimens of neonatal sepsis without previous sample processing. In addition, it does not show cross reactions in specimens infected with two other main causes of neonatal sepsis; Koagulase-negative Staphylococci and Klebsiella pneumoniae. The selected NWMN_1649 polypeptide shown shows success as a promising biomolecule where IC prototypes have been developed. This ICS provides fast, direct, sensitive and specific options for S. aureus detection which causes neonatal sepsis. Such tools are needed especially in limited countries of resources.

Stabilization of oil emulsion in soybean water using multilayers polypeptides: cationic polylysine and anionic acid polyglutamate

Oil-in-water emulsions are used as a shipping system for non-polar functional materials in various industries, including food, cosmetics, personal care products, agrochemicals and pharmaceuticals. However, emulsions tend to be damaged in conditions found in many commercial products. In this study, the functional performance of lipid droplets in emulsions is adjusted to electrostatic deposition of layers after the sequential layers of charged polypeptides contrary to their surface. Cationic Poly-L-lysine (PLL) and anionic poly-glutamic acid (PGA) are used as a pair of polypeptides imposed on the opposite (pH 4.0).

First, the primary emulsion (10% W / W soybean oil emulsion) is formed consisting of small lipid droplets (D32 = 500 μm) coated by natural surfactants (0.05% w / w Quilleta Saponin). Second, Cationic PLL is saved to the surface of anionic saponin-plated droplets. Third, Anionic PGA was saved to the surface of the cationic PLL-Saponin-plated droplets. We then assess the ability of coatings to protect lipid droplets from aggregation when pH (2.0-9.0), ionic power (0-350 mm), or temperature (30-90 ° C) changed. Primary, secondary and tertiary emulsion properties are monitored by measuring the average particle diameter (D32), electrical characteristics (ζ-potential), and micro from lipid droplets.

TAT Antibody
1-CSB-PA050213	Cusabio	EUR 266.40 EUR 234.00	100ug 50ug
Description: A polyclonal antibody against TAT. Recognizes TAT from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC:1/100-1/300.ELISA:1/40000

TAT Antibody
DF8469	Affbiotech	200ul	EUR 420

TAT siRNA
20-abx936139	Abbexa	EUR 661.20 EUR 878.40	15 nmol 30 nmol

TAT siRNA
20-abx936140	Abbexa	EUR 661.20 EUR 878.40	15 nmol 30 nmol

TAT Antibody
1-CSB-PA023175LA01HU	Cusabio	EUR 380.40 EUR 402.00	100ug 50ug
Description: A polyclonal antibody against TAT. Recognizes TAT from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IF; Recommended dilution: WB:1:500-1:5000, IF:1:50-1:200

TAT Antibody
1-CSB-PA024203	Cusabio	EUR 380.40 EUR 292.80	100ul 50ul
Description: A polyclonal antibody against TAT. Recognizes TAT from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:2000, WB:1:200-1:1000, IHC:1:25-1:100

Tat antibody
70R-8790	Fitzgerald	50 ug	EUR 560.4
Description: Affinity purified rabbit polyclonal Tat antibody

TAT antibody
39162-100ul	SAB	100ul	EUR 302.4

TAT Antibody
35946-100ul	SAB	100ul	EUR 302.4

TAT antibody
10-2250	Fitzgerald	200 ul	EUR 975.6
Description: Mouse monoclonal TAT antibody

TAT Antibody
ABD8469	Lifescience Market	100 ug	EUR 525.6

TAT siRNA
20-abx905471	Abbexa	EUR 661.20 EUR 878.40	15 nmol 30 nmol

TAT 14
B5721-1	ApexBio	1 mg	EUR 388.8

TAT (TFA)
HY-P0281A	MedChemExpress	5mg	EUR 854.4

Tat-NR2B9c
HY-P0117	MedChemExpress	10mM/1mL	EUR 1066.8

pCEP4- tat
PVT11063	Lifescience Market	2 ug	EUR 319.2

TAT BROTH
T20-100-10kg	Alphabiosciences	10 kg	EUR 1393.2

TAT BROTH
T20-100-2Kg	Alphabiosciences	2 Kg	EUR 349.2

TAT BROTH
T20-100-500g	Alphabiosciences	500 g	EUR 139.2

TAT Antibody
F51774-0.08ML	NSJ Bioreagents	0.08 ml	EUR 165

TAT Antibody
F51774-0.4ML	NSJ Bioreagents	0.4 ml	EUR 379

Horse TAT Complexes(TAT Complexes) ELISA Kit
QY-E120059	Qayee Biotechnology	96T	EUR 573.6

Human immunodeficiency virus-Tat Protein (HIV-Tat) ELISA
201-12-1915	SunredBio	96 tests	EUR 528
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids.

Human immunodeficiency virus-Tat Protein(HIV-Tat)ELISA
GA-E1931HM-48T	GenAsia Biotech	48T	EUR 346.8

Human immunodeficiency virus-Tat Protein(HIV-Tat)ELISA
GA-E1931HM-96T	GenAsia Biotech	96T	EUR 559.2

Human immunodeficiency virus-Tat Protein(HIV-Tat)ELISA
QY-E02393	Qayee Biotechnology	96T	EUR 433.2

TAT Conjugated Antibody
C35946	SAB	100ul	EUR 476.4

TAT cloning plasmid
CSB-CL023175HU-10ug	Cusabio	10ug	EUR 279.6
Description: A cloning plasmid for the TAT gene.

TAT Polyclonal Antibody
ES7344-100ul	ELK Biotech	100ul	EUR 334.8
Description: A Rabbit Polyclonal antibody against TAT from Human/Mouse/Rat. This antibody is tested and validated for IHC, WB, ELISA

TAT Polyclonal Antibody
ES7344-50ul	ELK Biotech	50ul	EUR 248.4
Description: A Rabbit Polyclonal antibody against TAT from Human/Mouse/Rat. This antibody is tested and validated for IHC, WB, ELISA

TAT 2-4
5-02001	CHI Scientific	4 x 1mg	Ask for price

HIV1 tat antibody
20-000601	Fitzgerald	500 ul	EUR 483.6
Description: Rabbit polyclonal HIV1 tat antibody

HIV1 tat antibody
20-000601F	Fitzgerald	500 ul	EUR 460.8
Description: Rabbit polyclonal HIV1 tat antibody

HIV1 tat antibody
20-000602	Fitzgerald	100 ug	EUR 159.6
Description: Rabbit polyclonal HIV1 tat antibody

HIV1 tat antibody
20-HS75	Fitzgerald	50 ul	EUR 307.2
Description: Sheep polyclonal HIV1 tat antibody

Sox2 TAT protein
30R-AS056	Fitzgerald	25 ug	EUR 327.6
Description: Purified recombinant Human Sox2 TAT protein

HIV1 tat protein
30-017001F	Fitzgerald	100 ug	EUR 1234.8
Description: Purified recombinant HIV1 tat protein

HIV1 tat protein
30-AH85	Fitzgerald	50 ug	EUR 1152
Description: Purified recombinant HIV1 tat protein

HIV1 tat antibody
10-007001	Fitzgerald	100 ug	EUR 483.6
Description: Mouse monoclonal HIV1 tat antibody

HIV1 tat antibody
10-H30K	Fitzgerald	100 ug	EUR 697.2
Description: Mouse monoclonal HIV1 tat antibody

TAT Polyclonal Antibody
ABP56345-003ml	Abbkine	0.03ml	EUR 189.6
Description: A polyclonal antibody for detection of TAT from Human, Mouse, Rat. This TAT antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human TAT

TAT Polyclonal Antibody
ABP56345-01ml	Abbkine	0.1ml	EUR 346.8
Description: A polyclonal antibody for detection of TAT from Human, Mouse, Rat. This TAT antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human TAT

TAT Polyclonal Antibody
ABP56345-02ml	Abbkine	0.2ml	EUR 496.8
Description: A polyclonal antibody for detection of TAT from Human, Mouse, Rat. This TAT antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human TAT

TAT Rabbit pAb
A6764-100ul	Abclonal	100 ul	EUR 369.6

TAT Rabbit pAb
A6764-200ul	Abclonal	200 ul	EUR 550.8

TAT Rabbit pAb
A6764-20ul	Abclonal	20 ul	EUR 219.6

TAT Rabbit pAb
A6764-50ul	Abclonal	50 ul	EUR 267.6

Nanog-TAT Protein
20-abx262148	Abbexa	EUR 6373.20 EUR 393.60 EUR 276.00	1 mg 20 ug 5 ug

TAT (48-57)
HY-P1575	MedChemExpress	5mg	EUR 308.4

TAT 2-4
HY-P1579	MedChemExpress	1mg	EUR 183.6

NANOG-TAT, Human
HY-P7391	MedChemExpress	50ug	EUR 639.6

Tat-NR2B9c (TFA)
HY-P0117A	MedChemExpress	25mg	EUR 968.4

TAT 2-4
H-7648.0500	Bachem	0.5mg	EUR 163.2
Description: Sum Formula: C132H240N66O29; CAS# [1159916-66-1] net

TAT 2-4
H-7648.1000	Bachem	1.0mg	EUR 262.8
Description: Sum Formula: C132H240N66O29; CAS# [1159916-66-1] net

SOX2-TAT, human
RC712-46	Bio Basic	5ug	EUR 125.26

TAT stable cells
SC012	GenTarget	2 x 106 cell/ml x 1ml	EUR 1800
Description: Stable cell line expressing codon humanized TAT gene and RFP with Blasticidin resistance

Anti-TAT antibody
STJ28847	St John's Laboratory	100 µl	EUR 332.4
Description: This nuclear gene encodes a mitochondrial protein tyrosine aminotransferase which is present in the liver and catalyzes the conversion of L-tyrosine into p-hydroxyphenylpyruvate. Mutations in this gene cause tyrosinemia (type II, Richner-Hanhart syndrome), a disorder accompanied by major skin and corneal lesions, with possible mental retardation. A regulator gene for tyrosine aminotransferase is X-linked.

Anti-TAT antibody
STJ95908	St John's Laboratory	200 µl	EUR 236.4
Description: Rabbit polyclonal to TAT.

Canine C-Peptide ELISA Kit
DLR-C-Peptide-c-48T	DL Develop	48T	EUR 632.4
Description: A competitive inhibition quantitative ELISA assay kit for detection of Canine C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Canine C-Peptide ELISA Kit
DLR-C-Peptide-c-96T	DL Develop	96T	EUR 825.6
Description: A competitive inhibition quantitative ELISA assay kit for detection of Canine C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Human C-Peptide ELISA Kit
DLR-C-Peptide-Hu-48T	DL Develop	48T	EUR 477.6
Description: A competitive inhibition quantitative ELISA assay kit for detection of Human C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Human C-Peptide ELISA Kit
DLR-C-Peptide-Hu-96T	DL Develop	96T	EUR 613.2
Description: A competitive inhibition quantitative ELISA assay kit for detection of Human C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Mouse C-Peptide ELISA Kit
DLR-C-Peptide-Mu-48T	DL Develop	48T	EUR 540
Description: A competitive inhibition quantitative ELISA assay kit for detection of Mouse C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Mouse C-Peptide ELISA Kit
DLR-C-Peptide-Mu-96T	DL Develop	96T	EUR 698.4
Description: A competitive inhibition quantitative ELISA assay kit for detection of Mouse C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Rat C-Peptide ELISA Kit
DLR-C-Peptide-Ra-48T	DL Develop	48T	EUR 560.4
Description: A competitive inhibition quantitative ELISA assay kit for detection of Rat C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Rat C-Peptide ELISA Kit
DLR-C-Peptide-Ra-96T	DL Develop	96T	EUR 726
Description: A competitive inhibition quantitative ELISA assay kit for detection of Rat C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Canine C-Peptide ELISA Kit
RDR-C-Peptide-c-48Tests	Reddot Biotech	48 Tests	EUR 668.4

Canine C-Peptide ELISA Kit
RDR-C-Peptide-c-96Tests	Reddot Biotech	96 Tests	EUR 928.8

Human C-Peptide ELISA Kit
RDR-C-Peptide-Hu-48Tests	Reddot Biotech	48 Tests	EUR 484.8

Human C-Peptide ELISA Kit
RDR-C-Peptide-Hu-96Tests	Reddot Biotech	96 Tests	EUR 667.2

Mouse C-Peptide ELISA Kit
RDR-C-Peptide-Mu-48Tests	Reddot Biotech	48 Tests	EUR 558

Mouse C-Peptide ELISA Kit
RDR-C-Peptide-Mu-96Tests	Reddot Biotech	96 Tests	EUR 771.6

Rat C-Peptide ELISA Kit
RDR-C-Peptide-Ra-48Tests	Reddot Biotech	48 Tests	EUR 583.2

Rat C-Peptide ELISA Kit
RDR-C-Peptide-Ra-96Tests	Reddot Biotech	96 Tests	EUR 806.4

Canine C-Peptide ELISA Kit
RD-C-Peptide-c-48Tests	Reddot Biotech	48 Tests	EUR 639.6

Canine C-Peptide ELISA Kit
RD-C-Peptide-c-96Tests	Reddot Biotech	96 Tests	EUR 888

Human C-Peptide ELISA Kit
RD-C-Peptide-Hu-48Tests	Reddot Biotech	48 Tests	EUR 464.4

Human C-Peptide ELISA Kit
RD-C-Peptide-Hu-96Tests	Reddot Biotech	96 Tests	EUR 638.4

Mouse C-Peptide ELISA Kit
RD-C-Peptide-Mu-48Tests	Reddot Biotech	48 Tests	EUR 535.2

Mouse C-Peptide ELISA Kit
RD-C-Peptide-Mu-96Tests	Reddot Biotech	96 Tests	EUR 738

Rat C-Peptide ELISA Kit
RD-C-Peptide-Ra-48Tests	Reddot Biotech	48 Tests	EUR 558

Rat C-Peptide ELISA Kit
RD-C-Peptide-Ra-96Tests	Reddot Biotech	96 Tests	EUR 771.6

Mouse TAT shRNA Plasmid
20-abx982152	Abbexa	EUR 961.20 EUR 1345.20	150 µg 300 µg

Rat TAT shRNA Plasmid
20-abx984656	Abbexa	EUR 961.20 EUR 1345.20	150 µg 300 µg

Human TAT shRNA Plasmid
20-abx954724	Abbexa	EUR 961.20 EUR 1345.20	150 µg 300 µg

TAT Antibody, HRP conjugated
1-CSB-PA023175LB01HU	Cusabio	EUR 380.40 EUR 402.00	100ug 50ug
Description: A polyclonal antibody against TAT. Recognizes TAT from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

TAT Antibody, FITC conjugated
1-CSB-PA023175LC01HU	Cusabio	EUR 380.40 EUR 402.00	100ug 50ug
Description: A polyclonal antibody against TAT. Recognizes TAT from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

TAT Antibody, Biotin conjugated
1-CSB-PA023175LD01HU	Cusabio	EUR 380.40 EUR 402.00	100ug 50ug
Description: A polyclonal antibody against TAT. Recognizes TAT from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA

Sheep TAT ELISA Kit
EST0509	Abclonal	96Tests	EUR 625.2

Human TAT ELISA Kit
EHT0509	Abclonal	96Tests	EUR 625.2

Porcine TAT ELISA Kit
EPT0509	Abclonal	96Tests	EUR 625.2

Monkey TAT ELISA Kit
EMKT0509	Abclonal	96Tests	EUR 625.2

Mouse TAT ELISA Kit
EMT0509	Abclonal	96Tests	EUR 625.2

Rat TAT ELISA Kit
ERT0509	Abclonal	96Tests	EUR 625.2

Rabbit TAT ELISA Kit
ERTT0509	Abclonal	96Tests	EUR 625.2

HIV1 tat protein (FITC)
65-017003F	Fitzgerald	50 ug	EUR 159.6
Description: Purified recombinant HIV1 tat protein (FITC)

Sox2-TAT Recombinant Protein
40-120-0005mg	ProSci	0.005 mg	EUR 311.1
Description: Sox2, also known as sex determining region Y (SRY)-box 2, belongs to a diverse family of structurally-related transcription factors whose primary structure contains a 79-residue DNA-binding domain, called high mobility group (HMG) box. It plays an essential role in maintaining the pluripotency of embryonic stem cells (ESC) and determination of cell fate. Microarray analysis showed that Sox2 regulates the expression of multiple genes involved in embryonic development including FGF-4, YES1 and ZFP206. Sox2 acts as a transcriptional activator after forming a ternary complex with Oct3/4 and a conserved non-coding DNA sequence (CNS1) located approximately 2 kb upstream of the RAX promoter. The introduction of Sox2, Oct4, Myc, and Klf4, into human dermal fibroblasts isolated from a skin biopsy of a healthy research fellow was sufficient to confer a pluripotent state upon the fibroblast genome. The reprogrammed cells thus obtained resemble ESC in morphology, gene expression, and in the capacity to form teratomas in immune-deficient mice. Sox2 and other transcription factors have been introduced into cells by DNA transfection, viral infection, or microinjection. Protein transduction using TAT fusion proteins represents an alternative methodology for introducing transcription factors and other nuclear proteins into primary as well as transformed cells. Recombinant human Sox2-TAT expressed in E. coli is a 36 kDa protein containing 330 amino-acid residues, including the 317 residues of full-length Sox2 and a 13-residue C-terminal TAT peptide (GGYGRKKRRQRRR).

Sox2-TAT Recombinant Protein
40-120-0025mg	ProSci	0.025 mg	EUR 437.1
Description: Sox2, also known as sex determining region Y (SRY)-box 2, belongs to a diverse family of structurally-related transcription factors whose primary structure contains a 79-residue DNA-binding domain, called high mobility group (HMG) box. It plays an essential role in maintaining the pluripotency of embryonic stem cells (ESC) and determination of cell fate. Microarray analysis showed that Sox2 regulates the expression of multiple genes involved in embryonic development including FGF-4, YES1 and ZFP206. Sox2 acts as a transcriptional activator after forming a ternary complex with Oct3/4 and a conserved non-coding DNA sequence (CNS1) located approximately 2 kb upstream of the RAX promoter. The introduction of Sox2, Oct4, Myc, and Klf4, into human dermal fibroblasts isolated from a skin biopsy of a healthy research fellow was sufficient to confer a pluripotent state upon the fibroblast genome. The reprogrammed cells thus obtained resemble ESC in morphology, gene expression, and in the capacity to form teratomas in immune-deficient mice. Sox2 and other transcription factors have been introduced into cells by DNA transfection, viral infection, or microinjection. Protein transduction using TAT fusion proteins represents an alternative methodology for introducing transcription factors and other nuclear proteins into primary as well as transformed cells. Recombinant human Sox2-TAT expressed in E. coli is a 36 kDa protein containing 330 amino-acid residues, including the 317 residues of full-length Sox2 and a 13-residue C-terminal TAT peptide (GGYGRKKRRQRRR).

KLF4-TAT Recombinant Protein
40-524-0005mg	ProSci	0.005 mg	EUR 311.1
Description: KLF4 is a member of the Kruppel-like factor (KLF) family of zinc finger transcription factors. Members of this family have in common 3 contiguous C2H2-type zinc fingers at the carboxyl terminus that comprise the DNA-binding domain. KLF4 is highly expressed in skin and gut epithelial tissues, but is also found in various other cells and tissues, including vascular endothelial cells, lymphocytes, lung, and testis. It is an important regulator of the cell cycle, transcription, and cell differentiation. Together with Sox2, Oct4, and cMyc, KLF4 can induce the reprogramming of primary human fibroblasts to a pluripotent state. KLF4 and other transcription factors can be introduced into cells by DNA transfection, viral infection, or microinjection. Protein transduction using TAT fusion proteins represents an alternative methodology for introducing transcription factors into primary as well as transformed cells. Recombinant Human KLF4-TAT is a 483 amino acid protein, including a 13-residue C-terminal TAT peptide, with a calculated molecular weight of 51.7kDa. Recombinant Human KLF4-TAT is a mixture of the expected sequence beginning at Met1 and a truncated isoform beginning at Tyr54. Due to post-translational modifications, SDS-PAGE gel shows bands at approximately 72 and 66kDa, under reduced conditions.

KLF4-TAT Recombinant Protein
40-524-0025mg	ProSci	0.025 mg	EUR 437.1
Description: KLF4 is a member of the Kruppel-like factor (KLF) family of zinc finger transcription factors. Members of this family have in common 3 contiguous C2H2-type zinc fingers at the carboxyl terminus that comprise the DNA-binding domain. KLF4 is highly expressed in skin and gut epithelial tissues, but is also found in various other cells and tissues, including vascular endothelial cells, lymphocytes, lung, and testis. It is an important regulator of the cell cycle, transcription, and cell differentiation. Together with Sox2, Oct4, and cMyc, KLF4 can induce the reprogramming of primary human fibroblasts to a pluripotent state. KLF4 and other transcription factors can be introduced into cells by DNA transfection, viral infection, or microinjection. Protein transduction using TAT fusion proteins represents an alternative methodology for introducing transcription factors into primary as well as transformed cells. Recombinant Human KLF4-TAT is a 483 amino acid protein, including a 13-residue C-terminal TAT peptide, with a calculated molecular weight of 51.7kDa. Recombinant Human KLF4-TAT is a mixture of the expected sequence beginning at Met1 and a truncated isoform beginning at Tyr54. Due to post-translational modifications, SDS-PAGE gel shows bands at approximately 72 and 66kDa, under reduced conditions.

Nanog-TAT Recombinant Protein
40-526-0005mg	ProSci	0.005 mg	EUR 311.1
Description: Nanog is a regulatory protein that is associated with undifferentiated pluripotent cells. The expression of Nanog, which is suppressed in all adult tissues, is restricted to embryonic stem cells and to certain pluripotent cancer cells. Decreased expression of Nanog is strongly correlated with cell differentiation. Nanog, most likely, acts as an intracellular regulator, which helps maintain pluripotency and self renewal via a STAT3 independent pathway. The introduction of Nanog, along with Sox2, Oct4, Lin28, into primary human fibroblasts was sufficient to confer a pluripotent state upon the fibroblast genome. The reprogrammed cells thus obtained resemble ESC in morphology and gene expression. Protein transduction using TAT fusion proteins represents an alternative methodology for introducing transcription factors into primary as well as transformed cells. Recombinant human Nanog-TAT is a 36.1 kDa protein, which is synthesized as a 304 amino acid polypeptide plus a 13- residue C-terminal TAT peptide.

Nanog-TAT Recombinant Protein
40-526-002mg	ProSci	0.02 mg	EUR 437.1
Description: Nanog is a regulatory protein that is associated with undifferentiated pluripotent cells. The expression of Nanog, which is suppressed in all adult tissues, is restricted to embryonic stem cells and to certain pluripotent cancer cells. Decreased expression of Nanog is strongly correlated with cell differentiation. Nanog, most likely, acts as an intracellular regulator, which helps maintain pluripotency and self renewal via a STAT3 independent pathway. The introduction of Nanog, along with Sox2, Oct4, Lin28, into primary human fibroblasts was sufficient to confer a pluripotent state upon the fibroblast genome. The reprogrammed cells thus obtained resemble ESC in morphology and gene expression. Protein transduction using TAT fusion proteins represents an alternative methodology for introducing transcription factors into primary as well as transformed cells. Recombinant human Nanog-TAT is a 36.1 kDa protein, which is synthesized as a 304 amino acid polypeptide plus a 13- residue C-terminal TAT peptide.

Lin28-TAT Recombinant Protein
40-562-0005mg	ProSci	0.005 mg	EUR 311.1
Description: Lin28 is a RNA-binding protein that belongs to a diverse family of structurally-related transcription factors. Lin28 is found abundantly in embryonic stem cells (ESCs), and to a lesser extent in placenta and testis. Lin28 has been shown to block let-7 microRNA processing and maturation, a necessary step in the differentiation of stem cells and certain cancer cell lines. Together with Sox2, Oct4, and Nanog, Lin28 can induce the reprogramming of primary human fibroblasts to a pluripotent state. Lin28 and other regulatory proteins can be introduced into cells by DNA transfection, viral infection, or microinjection. Protein transduction using TAT fusion proteins represents an alternative methodology for introducing proteins into primary as well as transformed cells. Recombinant human Lin28-TAT is a 24.4 kDa protein containing 222 amino acid residues, including 13- residue C-terminal TAT peptide.

Lin28-TAT Recombinant Protein
40-562-0025mg	ProSci	0.025 mg	EUR 437.1
Description: Lin28 is a RNA-binding protein that belongs to a diverse family of structurally-related transcription factors. Lin28 is found abundantly in embryonic stem cells (ESCs), and to a lesser extent in placenta and testis. Lin28 has been shown to block let-7 microRNA processing and maturation, a necessary step in the differentiation of stem cells and certain cancer cell lines. Together with Sox2, Oct4, and Nanog, Lin28 can induce the reprogramming of primary human fibroblasts to a pluripotent state. Lin28 and other regulatory proteins can be introduced into cells by DNA transfection, viral infection, or microinjection. Protein transduction using TAT fusion proteins represents an alternative methodology for introducing proteins into primary as well as transformed cells. Recombinant human Lin28-TAT is a 24.4 kDa protein containing 222 amino acid residues, including 13- residue C-terminal TAT peptide.

HIV1 tat antibody (FITC)
60-00602-3F	Fitzgerald	50 ug	EUR 648
Description: Rabbit polyclonal anti-tat HIV1 antibody (FITC)

HIV1 tat antibody (biotin)
60-00602-5	Fitzgerald	50 ug	EUR 548.4
Description: Rabbit polyclonal anti-tat HIV1 antibody (Biotin)

HIV1 tat antibody (HRP)
61-007002	Fitzgerald	1 mg	EUR 457.2
Description: Mouse monoclonal HIV1 tat antibody (HRP)

HIV1 tat antibody (FITC)
61-007003	Fitzgerald	50 ug	EUR 213.6
Description: Mouse monoclonal HIV1 tat antibody (FITC)

HIV1 tat antibody (biotin)
61-007005	Fitzgerald	50 ug	EUR 418.8
Description: Mouse monoclonal HIV1 tat antibody (biotin)

Recombinant Human Nanog-TAT
7-05665	CHI Scientific	5µg	Ask for price

Recombinant Human Nanog-TAT
7-05666	CHI Scientific	20µg	Ask for price

Recombinant Human Nanog-TAT
7-05667	CHI Scientific	1mg	Ask for price

TIGAR-TAT Recombinant Protein
40-575-0005mg	ProSci	0.005 mg	EUR 311.1
Description: TIGAR is a p53-inducible enzyme that catalyzes the hydrolysis of fructose-2-6 bisphosphate (F-2-6-BP) to fructose-6-phosphate and inorganic phosphate. F-2-6-BP is a powerful activator of 6-phosphofructose-1 kinase, the rate limiting enzyme of glycolysis. By lowering the intracellular level of F-2-6-BP, TIGAR expression leads to increased glucose processing via the pentose phosphate pathway, the major cellular source for NADPH. Protein transduction using TAT fusion proteins represents an alternative methodology for introducing transcription factors and other intracellular proteins into primary as well as transformed cells. Recombinant human TIGAR-TAT expressed in E. coli is a 36 kDa protein containing 284 amino-acid residues, including the 271 residues of full-length TIGAR fused to a 13-residue C-terminal peptide containing the TAT transduction domain (GGYGRKKRRQRRR).

TIGAR-TAT Recombinant Protein
40-575-0025mg	ProSci	0.025 mg	EUR 437.1
Description: TIGAR is a p53-inducible enzyme that catalyzes the hydrolysis of fructose-2-6 bisphosphate (F-2-6-BP) to fructose-6-phosphate and inorganic phosphate. F-2-6-BP is a powerful activator of 6-phosphofructose-1 kinase, the rate limiting enzyme of glycolysis. By lowering the intracellular level of F-2-6-BP, TIGAR expression leads to increased glucose processing via the pentose phosphate pathway, the major cellular source for NADPH. Protein transduction using TAT fusion proteins represents an alternative methodology for introducing transcription factors and other intracellular proteins into primary as well as transformed cells. Recombinant human TIGAR-TAT expressed in E. coli is a 36 kDa protein containing 284 amino-acid residues, including the 271 residues of full-length TIGAR fused to a 13-residue C-terminal peptide containing the TAT transduction domain (GGYGRKKRRQRRR).

Tyrosine Aminotransferase (TAT) Antibody
20-abx131664	Abbexa	EUR 526.80 EUR 159.60 EUR 1479.60 EUR 710.40 EUR 393.60	100 ug 10 ug 1 mg 200 ug 50 ug

Tyrosine Aminotransferase (TAT) Antibody
20-abx131665	Abbexa	EUR 510.00 EUR 159.60 EUR 1446.00 EUR 693.60 EUR 393.60	100 ug 10 ug 1 mg 200 ug 50 ug

TIGAR-TAT (C12ORF5) Protein
20-abx261124	Abbexa	EUR 4101.60 EUR 393.60 EUR 276.00	1 mg 25 ug 5 ug

Anti-ATTY/TAT Antibody
A00622	BosterBio	100ug/vial	EUR 352.8

Active Tyrosine Aminotransferase (TAT)
4-APD862Mu01	Cloud-Clone	EUR 797.38 EUR 337.20 EUR 2660.16 EUR 966.72 EUR 1813.44 EUR 609.60 EUR 6470.40	100 ug 10ug 1 mg 200 ug 500 ug 50ug 5 mg
Description: Recombinant Mouse Tyrosine Aminotransferase expressed in: Available from E.coli, Yeast, Baculovirus and Mammalian cells

TAT (His) Lentiviral particles
LVP019	GenTarget	5x107 IFU/ml x 200ul	EUR 418.8
Description: pre-made lentiviral particles expressing HIV TAT gene with N-term His tag

Goat TAT ELISA Kit
EGTT0509	Abclonal	96Tests	EUR 625.2

Anserini TAT ELISA Kit
EAT0509	Abclonal	96Tests	EUR 625.2

The electrical characteristics of droplets can be modulated by controlling the number and type of layer used. Primary emulsions have the best resistance to various environmental conditions, while secondary emulsions have the worst, suggest electrostatic deposits may only be used to get certain functions. Interestingly, PLL regardless of the surface of the secondary emulsion at high salt concentrations due to electrostatic screening, which increases their salt stability. This phenomenon may be useful for several food applications, eg, have cationic droplets during food storage, but are anionic in the human body.